Ke Wang

机构：Jinan University, Xian Yang Central Hospital · ORCID：0000-0003-1697-1373

发表论文 128 篇 · 总被引 2996 次 · h-index 30

代表论文

• The dichotomous roles of microbial-modified bile acids 7-oxo-DCA and isoDCA in intestinal tumorigenesis (2024 · Proceedings of the National Academy of Sciences · 被引 20)
• SIRT7 regulates T-cell antitumor immunity through modulation BCAA and fatty acid metabolism (2025 · Cell Death and Differentiation · 被引 17)
• The clinical-grade CBP/ p300 inhibitor CCS1477 represses the global NRF2-dependent cytoprotective transcription program and re-sensitizes cancer cells to chemotherapeutic drugs (2025 · Free Radical Biology and Medicine · 被引 13)
• The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression (2025 · Cancer Research · 被引 11)
• Systemic activation of NRF2 contributes to the therapeutic efficacy of clinically-approved KRAS-G12C anti-cancer drugs (2025 · British Journal of Cancer · 被引 6)
• Revealing GRP75-MediatedMitochondrial Stability ThatPromotes Breast Cancer Survival through Subcellular Anchoring of 70kDa Heat Shock Protein Inhibitors (2025 · Journal of Medicinal Chemistry · 被引 4)